Evogene Ltd. — Report Publication Announcement 2016

Jul 25, 2016

_________ false

C003����� ��"�2PublicEVOGENE LTD10571Corporation no: 512838723Stock Exchange/Market: -12369381Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121 , ,Tel: 08-9311900 , Fax: 08-9466724E.mail address: ofer.haviv@evogene.comReported via MAGNA: 25/07/2016              Time of broadcast: 14:01 13:54:30

Company site:		www.evogene.com

Reference: 2016-02-089752

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000 The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on	Press Release: Evogene Q2 2016 Earnings Announcement Schedule

Evogene_Q2_2016_Results_Schedule_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 29/06/2016
- - -
Name of the Signatory: : Masliah Sassi , Position of Signatory in the reporting corporation: Adv., Corporate Secretary , Name of Employer Company: .
Eizenberg Aharon 19 Rehovot 7629008 Telephone: 08-9311971 , Facsimile: 08-9466724 , E-mail: sassi.masliah@evogene.com 1